Moderna picks Kenya for African mRNA facilityModerna says it will build a messenger RNA (mRNA) therapeutics plant in Kenya at a cost of up to $500 million. The facility will make mRNA active ingredients and could be expanded to produce finished therapies such as Moderna’s COVID-19 vaccine. The firm’s announcement advances a promise it made in October 2021 to build an mRNA facility somewhere in Africa. Last month, BioNTech, which with Pfizer produces another mRNA COVID-19 vaccine, said it would establish modular production systems in Africa.
Watching the growth of manufacturing of all different kinds in Africa is really cool; here's hoping for more.
No comments:
Post a Comment
looks like Blogger doesn't work with anonymous comments from Chrome browsers at the moment - works in Microsoft Edge, or from Chrome with a Blogger account - sorry! CJ 3/21/20